Exhibit 99



                      FORWARD LOOKING STATEMENTS STATEMENT

The Private Securities Litigation Reform Act of 1995 provides a safe harbor from
civil litigation for forward looking statements accompanied by meaningful
cautionary statements. These statements identify important factors that could
cause actual results to differ materially from those that might be projected.
Meridian's continued growth depends, in part, on its ability to introduce into
the marketplace enhancements of existing products or new products that
incorporate technological advances, meet customer requirements and respond to
products developed by Meridian's competition. While Meridian has introduced
approximately 35 internally-developed products since 1991, there can be no
assurance that it will be successful in the future in introducing such products
on a timely basis. Ongoing consolidations of reference laboratories and
formation of multi-hospital alliances may cause adverse changes to pricing and
distribution. Costs and difficulties in complying with laws and regulations
administered by the United States Food and Drug Administration can result in
unanticipated expenses and delays and interruptions to the sale of new and
existing products. One of Meridian's main growth strategies is acquisition of
companies and product lines. There can be no assurance that additional
acquisitions will be consummated or that, if consummated, will be successful and
the acquired businesses successfully integrated into Meridian's operations.